NDC 51662-1377
Ondansetron 2 mg per 1 mL injection
On the label: HF Acquisition Co. LLC. DBA HealthFirst. It's repackaged: HF Acquisition Co. LLC. DBA HealthFirst rebottles it from Fresenius Kabi, LLC's NDC 63323-374.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Fresenius Kabi USA, LLC | Grand Island, NY, United States | Makes it and tests it | Problems found, fixed voluntarilyOct 13, 2023 · 14 inspections, 2 with FDA action |
Repackaging site
- HF Acquisition Co LLC, Mukilteo, WA, United States · relabels it
Recalls
- May 22, 2019 · Class III · Fresenius Kabi USA, LLC
Failed Impurities/Degradation Specifications.
Lots: Lot #: 6018699, Exp. 12/2021 - Sep 27, 2012 · Class II · Fresenius Kabi USA, LLC
Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.
Lots: Lot 6003930, exp. date 04/2014
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Ondansetron: every company that makes it
- Form
- injection, intramuscular; intravenous
- Strength
- 2 mg per 1 mL
- Approval
- ANDA ANDA076974
- On the market since
- May 21, 2020
- Package NDCs
51662-1377-1- Official label
- DailyMed (National Library of Medicine), updated Feb 26, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?